Ovotoxic environmental chemicals: Indirect endocrine disruptors

Endocrine Disruptors: Effects on Male and Female Reproductive Systems, Second Edition

Volumn , Issue , 2004, Pages 67-100

  Devine, Patrick J ^a   Hoyer, Patricia B ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649184158     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (160)

1. Mattison, D.R., Reproductive Toxicology, Raven Press, New York, 1985, 109.
2. Hollier, L.M., Leveno, K.J., Kelly, M.A., McIntire, D.D., and Cunningham, F.G., Maternal age and malformations in singleton births., Obstet. Gynecol., 96, 701, 2000.
3. Richards, J.S., Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation, Physiol. Rev., 60, 51, 1980.
4. Hirshfield, A.N., Development of follicles in the mammalian ovary, Int. Rev. Cytol., 124, 43, 1991.
5. Christiansen, C., Christensen, M.S., McNair, P., Hagen, C., Stocklund, K.E., and Transbol, I., Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females, Eur. J. Clin. Invest., 10, 273, 1980.
6. Bruning, P.F., Pit, M.J., de Jong-Bakker, M., van den Ende, A., Hart, A., and van Enk, A., Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer, Br. J. Cancer, 61, 308, 1990.
7. Oparil, S., Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection, Hypertension, 33, 170, 1999.
8. Dhar, H.L., Gender, aging, health and society, J. Assoc. Physicians India, 49, 1012, 2001.
9. Paganini-Hill, A. and Henderson, V.W., Estrogen deficiency and risk of Alzheimer’s disease in women, Am. J. Epidemiol., 140, 256, 1994.
10. Sowers, M.R. and La Pietra, M.T., Menopause: its epidemiology and potential association with chronic diseases, Epidemiol. Rev., 17, 287, 1995.
11. Mant, J.W.F. and Vessey, M.P., Trends in cancer incidence and mortality, Cold Spring Harbor Laboratory Press, Plainview, NY, 1994, 19, 287.
12. Hoyer, P.B. and Sipes, I.G., Assessment of follicle destruction in chemical-induced ovarian toxicity, Annu. Rev. Pharmacol. Toxicol., 36, 307, 1996.
13. Buccione, R., Schroeder, A.C., and Eppig, J.J., Interactions between somatic cells and germ cells throughout mammalian oogenesis, Biol. Reprod., 43, 543, 1990.
14. Mattison, D.R. and Schulman, J.D., How xenobiotic compounds can destroy oocytes, Contemporary OB/GYN, 15, 157, 1980.
15. Tilly, J.L., Kowalski, K.I., Johnson, A.L., and Hsueh, A.J., Involvement of apoptosis in ovarian follicular atresia and postovulatory regression, Endocrinology, 129, 2799, 1991.
16. Wyllie, A.H., Kerr, J.F., and Currie, A.R., Cell death: the significance of apoptosis, Int. Rev. Cytol., 68, 251, 1980.
17. Compton, M.M., A biochemical hallmark of apoptosis: internucleosomal degradation of the genome, Cancer Metastasis Rev., 11, 105, 1992.
18. Morita, Y. and Tilly, J.L., Oocyte apoptosis: like sand through an hourglass, Dev. Biol., 213, 1, 1999.
19. McNatty, K.P., Fidler, A.E., Juengel, J.L., Quirke, L.D., Smith, P.R., Heath, D.A., Lundy, T., O’Connell, A., and Tisdall, D.J., Growth and paracrine factors regulating follicular formation and cellular function, Mol. Cell. Endocrinol., 163, 11, 2000.
20. Springer, L.N., McAsey, M.E., Flaws, J.A., Tilly, J.L., Sipes, I.G., and Hoyer, P.B., Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats, Toxicol. Appl. Pharmacol., 139, 394, 1996.
21. Boone, D.L., Yan, W., and Tsang, B.K., Identification of a deoxyribonuclease I-like endonuclease in rat granulosa and luteal cell nuclei, Biol. Reprod., 53, 1057, 1995.
22. Payne, C.M., Bernstein C., and Bernstein H., Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways, Leuk. Lymphoma, 19, 43, 1995.
23. Meirow, D., Lewis, H., Nugent, D., and Epstein, M., Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool, Hum. Reprod., 14, 1903, 1999.
24. Generoso, W., Stout, S.K., and Huff, S.W., Effects of alkylating chemicals on reproductive capacity of adult female mice, Mutat. Res., 13, 171, 1971.
25. Jarrell, J.F., Bodo, L., Younglai, E.V., Barr, R.D., and O’Connell, G.J., The shortterm reproductive toxicity of cyclophosphamide in the female rat, Reprod. Toxicol., 5, 481, 1991.
26. Davis, B.J., Maronpot, R.R., and Heindel, J.J., Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats, Toxicol. Appl. Pharmacol., 128, 216, 1994.
27. Hooser, S.B., Douds, D.P., DeMerell, D.G., Hoyer, P.B., and Sipes, I.G., Long-term ovarian and gonadotropin changes in mice exposed to 4-vinylcyclohexene., Reprod. Toxicol., 8, 315, 1994.
28. Hedge, G.A., Colby, H.D., and Goodman, R.L., Clinical Endocrine Physiology, Saunders, Philadelphia, 1987, 189.
29. Mayer, L.P., Pearsall, N.A., Christian, P.J., Devine, P.J., Payne, C.M., McCuskey, M.K., Marion, S.L., Sipes, I.G., and Hoyer, P.B., Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide, Reprod. Toxicol., 16, 775, 2002.
30. Byrne, J., Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring, Teratology, 59, 210, 1999.
31. Dobson, R.L. and Felton, J.S., Female germ cell loss from radiation and chemical exposures, Am. J. Ind. Med., 4, 175, 1983.
32. Chapman, R.M., Gonadal injury resulting from chemotherapy, Am. J. Ind. Med., 4, 149, 1983.
33. Damewood, M.D. and Grochow, L.B., Prospects for fertility after chemotherapy or radiation for neoplastic disease, Fertil. Steril., 45, 443, 1986.
34. Revel, A. and Laufer, N., Protecting female fertility from cancer therapy, Mol. Cell. Endocrinol., 187, 83, 2002.
35. Sobrinho, L.G., Levine, R.A., and DeConti, R.C., Amenorrhea in patients with Hodgkin’s disease treated with antineoplastic agents, Am. J. Obstet. Gynecol., 109, 135, 1971.
36. Warne, G.L., Fairley, K.F., Hobbs, J.B., and Martin, F.I., Cyclophosphamide-induced ovarian failure, N. Engl. J. Med., 289, 1159, 1973.
37. Koyama, H., Wada, T., Nishizawa, Y., Iwanaga, T., and Aoki, Y., Cyclophosphamideinduced ovarian failure and its therapeutic significance in patients with breast cancer, Cancer, 39, 1403, 1977.
38. Thomson, A.B., Critchley, H.O., Kelnar, C.J., and Wallace, W.H., Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation., Best Pract. Res. Clin. Endocrinol. Metab., 16, 311, 2002.
39. Blumenfeld, Z., Dann, E., Avivi, I., Epelbaum, R., and Rowe, J.M., Fertility after treatment for Hodgkin’s disease, Ann. Oncol., 13, 138, 2002.
40. Miller, J.J. 3rd and Cole, L.J., Changes in mouse ovaries after prolonged treatment with cyclophosphamide, Proc. Soc. Exp. Biol. Med., 133, 190, 1970.
41. Shiromizu, K., Thorgeirsson, S.S., and Mattison, D.R., Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice, Pediatr. Pharmacol. (New York), 4, 213, 1984.
42. Plowchalk, D.R. and Mattison, D.R., Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide, Toxicol. Appl. Pharmacol., 107, 472, 1991.
43. Ataya, K.M., McKanna, J.A., Weintraub, A.M., Clark, M.R., and LeMaire, W.J., A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapyinduced ovarian follicular loss in rats, Cancer Res., 45, 3651, 1985.
44. Jarrell, J., Lai, E.V., Barr, R., McMahon, A., Belbeck, L., and O’Connell, G., Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat, Cancer Res., 47, 2340, 1987.
45. Plowchalk, D.R. and Mattison, D.R., Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function, Reprod. Toxicol., 6, 411, 1992.
46. Baird, D.D. and Wilcox, A.J., Cigarette smoking associated with delayed conception, JAMA, 253, 2979, 1985.
47. Everson, R.B., Sandler, D.P., Wilcox, A.J., Schreinemachers, D., Shore, D.L., and Weinberg, C., Effect of passive exposure to smoking on age at natural menopause, Br. Med. J. (Clin. Res. Ed.), 293, 792, 1986.
48. Jick, H., Porter, J., and Morrison, A.S., Relation between smoking and age of natural menopause, Lancet, 1, 1354, 1977.
49. Shiverick, K.T. and Salafia, C., Cigarette smoking and pregnancy I: ovarian, uterine and placental effects, Placenta, 20, 265, 1999.
50. Mattison, D.R., Plowchalk, B.S., Meadows, M.J., Miller, M.M., Malek, A., and London, S., The effect of smoking on oogenesis, fertilization, and implantation, Semin. Reprod. Endocrinol., 7, 291, 1989.
51. Weinberg, C.R., Wilcox, A.J., and Baird, D.D., Reduced fecundability in women with prenatal exposure to cigarette smoking, Am. J. Epidemiol, 129, 1072, 1989.
52. Vahakangas, K., Rajaniemi, H., and Pelkonen, O., Ovarian toxicity of cigarette smoke exposure during pregnancy in mice, Toxicol. Lett., 25, 75, 1985.
53. Stedman, R.L., The chemical composition of tobacco and tobacco smoke, Chem. Rev., 68, 153, 1968.
54. Van Voorhis, B.J., Syrop, C.H., Hammitt, D.G., Dunn, M.S., and Snyder, G.D., Effects of smoking on ovulation induction for assisted reproductive techniques, Fertil. Steril., 58, 981, 1992.
55. Barbieri, R.L., McShane, P.M., and Ryan, K.J., Constituents of cigarette smoke inhibit human granulosa cell aromatase, Fertil. Steril., 46, 232, 1986.
56. Yeh, J. and Barbieri, R.L., Effects of smoking on steroid production, metabolism, and estrogen related diseases, Semin. Reprod. Endocrinol., 7, 326, 1989.
57. Krarup, T., 9:10-dimethyl-1:2-benzantracene induced ovarian tumours in mice, Acta Pathol. Microbiol. Scand., 70, 241, 1967.
58. Krarup, T., Oocyte destruction and ovarian tumorigenesis after direct application of a chemical carcinogen (9:0-dimethyl-1:2-benzanthrene) to the mouse ovary, Int. J. Cancer, 4, 61, 1969.
59. Mattison, D.R., Difference in sensitivity of rat and mouse primordial oocytes to destruction by polycyclic aromatic hydrocarbons, Chem. Biol. Interact., 28, 133, 1979.
60. Basler, A. and Rohrborn, G., Chromosome aberrations in oocytes of NMRI mice and bone marrow cells of Chinese hamsters induced with 3,4-benzpyrene, Mutat. Res., 38, 327, 1976.
61. Gulyas, B.J. and Mattison, D.R., Degeneration of mouse oocytes in response to polycyclic aromatic hydrocarbons, Anat. Rec., 193, 863, 1979.
62. Mattison, D.R. and Thorgeirsson, S.S., Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice, Cancer Res., 39, 3471, 1979.
63. Borman, S.M., Christian, P.J., Sipes, I.G., and Hoyer, P.B., Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index, Toxicol. Appl. Pharmacol., 167, 191, 2000.
64. MacKenzie, K.M. and Angevine, D.M., Infertility in mice exposed in utero to benzo(a)pyrene, Biol. Reprod., 24, 183, 1981.
65. Mattison, D.R., Shiromizu, K., and Nightingale, M.S., Oocyte destruction by polycyclic aromatic hydrocarbons, Am. J. Ind. Med., 4, 191, 1983.
66. Mattison, D.R. and Nightingale, M.R., The biochemical and genetic characteristics of murine ovarian aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity and its relationship to primordial oocyte destruction by polycyclic aromatic hydrocarbons, Toxicol. Appl. Pharmacol., 56, 399, 1980.
67. Park, J., Kim, Y., Park, D., Choi, K., Park, S., and Moon, Y., An outbreak of hematopoietic and reproductive disorders due to solvents containing 2-bromopropane in an electronic factory, South Korea: Epidemiological survey, J. Occup. Health, 39, 138, 1997.
68. Koh, J.M., Kim, C.H., Hong, S.K., Lee, K.U., Kim, Y.T., Kim, O.J., and Kim, G.S., Primary ovarian failure caused by a solvent containing 2-bromopropane, Eur. J. Endocrinol., 138, 554, 1998.
69. Takeuchi, Y., Ichihara, G., and Kamijima, M., A review of toxicity of 2-bromopropane: mainly on its reproductive toxicity, J. Occup. Health, 39, 191, 1997.
70. National Toxicology Program (NTP), NTP-CERHR Expert Panel Report 2-BP-02, U.S. Department of Health and Human Services, Public Health Service National Institutes of Health Public Information, Research Triangle Park, NC, 2002.
71. National Toxicology Program (NTP), NTP-CERHR Expert Panel Report 1-BP-02, U.S. Department of Health and Human Services, Public Health Service National Institutes of Health Public Information, Research Triangle Park, NC, 2002.
72. Sekiguchi, S., Asano, G., Suda, M., and Honma, T., Influence of 2-bromopropane on reproductive system-short-term administration of 2-bromopropane inhibits ovulation in F344 rats, Toxicol. Ind. Health, 16, 277, 2001.
73. Sekiguchi, S., Suda, M., Zhai, Y.L., and Honma, T., Effects of 1-bromopropane, 2-bromopropane, and 1,2-dichloropropane on the estrous cycle and ovulation in F344 rats, Toxicol. Lett., 126, 41, 2002.
74. Yu, X.Z., Kamijima, M., Ichihara, G., Li, W., Kitoh, J., Xie, Z., Shibata, E., Hisanaga, N., and Takeuchi, Y., 2-Bromopropane causes ovarian dysfunction by damaging primordial follicles and their oocytes in female rats, Toxicol. Appl. Pharmacol., 159, 185, 1999.
75. Yamada, T., Ichihara, G., Wang, H., Yu, X., Maeda, K., Tsukamura, H., Kamijima, M., Nakajima, T., and Takeuchi, Y., Exposure to 1-bromopropane causes ovarian dysfunction in rats, Toxicol. Sci., 71, 96, 2003.
76. IARC (International Agency for Research on Cancer), Report No. 60, IARC monographs on the evaluation of carcinogenic risks to humans: some industrial chemicals, Lyon, France, 1994.
77. Melnick, R.L. and Huff, J., 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and humans, Rev. Environ. Contam. and Tox., 124, 111, 1992.
78. Thornton-Manning, J.R., Dahl, A.R., Bechtold, W.E., Griffith, W.C. Jr., and Henderson, R.F., Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene, Carcinogenesis, 16, 1723, 1995.
79. Doerr, J.K., Hooser, S.B., Smith, B.J., and Sipes, I.G., Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: role of diepoxides, Chem. Res. Toxicol., 8, 963, 1995.
80. Bond, J.A., Recio, L., and Andjelkovich, D., Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace, Carcinogenesis, 16, 165, 1995.
81. Rappaport, S.M. and Fraser, D.A., Air sampling and analysis in a rubber vulcanization area, Am. Ind. Hyg. Assoc. J., 38, 205, 1977.
82. Smith, B.J., Mattison, D.R., and Sipes, I.G., The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity, Toxicol. Appl. Pharmacol., 105, 372, 1990.
83. National Toxicology Program (NTP), NTP Technical Report No. 303, U.S. Department of Health and Human Services, Public Health Service National Institutes of Health Public Information, Research Triangle Park, NC, 1986.
84. Grizzle, T.B., George, J.D., Fail, P.A., Seely, J.C., and Heindel, J.J., Reproductive effects of 4-vinylcyclohexene in Swiss mice assessed by a continuous breeding protocol, Fundam. Appl. Toxicol., 22, 122, 1994.
85. Kao, S.-W., Sipes, I.G., and Hoyer, P.B., Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice, Reprod. Toxicol., 13, 67, 1999.
86. National Toxicology Program (NTP), NTP Technical Report No. 362, U.S. Department of Health and Human Services, Public Health Service National Institutes of Health Public Information, Research Triangle Park, NC, 1989.
87. Bevan C., Keller, D.A., Panepinto, A.S., and Bently, K.S., Effect of 4-vinylcyclohexene on micronucleus formation in the bone marrow of rats and mice, Drug Chem. Toxicol., 24, 273, 2001.
88. Kari, F.W., Huff, J.E., Leininger, J., Haseman, J.K., and Eustis, S.L., Toxicity and carcinogenicity of nitrofurazone in F344/N rats and B6C3F1 mice, Food Chem. Toxicol., 27, 129, 1989.
89. Hemminki, K., Falck, K., and Vainio, H., Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals: epoxides, glycidyl ethers, methylating and ethylating agents, halogenated hydrocarbons, hydrazine derivatives, aldehydes, thiuram and dithiocarbamate derivatives, Arch. Toxicol., 46, 277, 1980.
90. Sevcik, M.L. and Jarrell, J.F., Comprehensive Toxicology, 10, Elsevier Press, Oxford, 1997, 369.
91. Ataya, K., Rao, L.V., Lawrence, E., and Kimmel, R., Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys., Biol. Reprod., 52, 365, 1995.
92. Krarup, T., Oocyte survival in the mouse ovary after treatment with 9,10-dimethyl-1,2-benzanthracene, J. Endocrinol., 46, 483, 1970.
93. Mattison, D.R., Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice, Toxicol. Appl. Pharmacol., 53, 249, 1980.
94. Swartz, W.J. and Mattison, D.R., Benzo(a)pyrene inhibits ovulation in C57BL/6N mice, Anat. Rec., 212, 268, 1985.
95. Kavlock, R., Boekelheide, K., Chapin, R., Cunningham, M., Faustman, E., Foster, P., Golub, M., Henderson, R., Hinberg, I., Little, R., Seed, J., Shea, K., Tabacova, S., Tyl, R., Williams, P., and Zacharewski, T., NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate, Reprod. Toxicol., 16, 529, 2002.
96. Lan, Z.J., Gu, P., Xu, X., Jackson, K.J., DeMayo, F.J., O’Malley, B.W., and Cooney, A.J., GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility, EMBO J., 22, 4070, 2003.
97. Blount, B.C., Silva, M.J., Caudill, S.P., Needham, L.L., Pirkle, J.L., Sampson, E.J., Lucier, G.W., Jackson, R.J., and Brock, J.W., Levels of seven urinary phthalate metabolites in a human reference population, Environ. Health Perspect., 108, 979, 2000.
98. Fay, M., Donohue, J.M., and De Rosa, C., ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for Toxic Substances and Disease Registry, Toxicol. Ind. Health, 15, 651, 1999.
99. Tabacova, S., Little, R., and Balabaeva, L., Maternal exposure to phthalates and complications of pregnancy, Epidemiology, 10, S127, 1999.
100. Aldyreva, M.V., Klimova, T.S., Iziumova, A.S., and Timofeevskaia, L.A., [The effect of phthalate plasticizers on the generative function], Gig. Tr. Prof. Zabol., 25, 1975.
101. Lovekamp-Swan, T. and Davis, B.J., Mechanisms of phthalate ester toxicity in the female reproductive system, Environ. Health Perspect., 111, 139, 2003.
102. Fan, L.Q., Cattley, R.C., and Corton, J.C., Tissue-specific induction of 17 betahydroxysteroid dehydrogenase type IV by peroxisome proliferator chemicals is dependent on the peroxisome proliferator-activated receptor alpha, J. Endocrinol., 158, 237, 1998.
103. Lovekamp, T.N. and Davis, B.J., Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells, Toxicol. Appl. Pharmacol., 172, 217, 2001.
104. Lovekamp-Swan, T., Jetten, A.M., and Davis, B.J., Dual activation of PPARalpha and PPARgamma by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells, Mol. Cell. Endocrinol., 201, 133, 2003.
105. Safe, S. and Krishnan, V., Chlorinated hydrocarbons: estrogens and antiestrogens, Toxicol. Lett., 82-83, 731, 1995.
106. Li, X., Johnson, D.C., and Rozman, K.K., Effects of 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) on estrous cyclicity and ovulation in female Sprague-Dawley rats, Toxicol. Lett., 78, 219, 1995.
107. Li, X., Johnson, D.C., and Rozman, K.K., Reproductive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female rats: ovulation, hormonal regulation, and possible mechanism(s), Toxicol. Appl. Pharmacol., 133, 321, 1995.
108. Moran, F.M., Conley, A.J., Corbin, C.J., Enan, E., VandeVoort, C., Overstreet, J.W., and Lasley, B.L., 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases estradiol production without altering the enzyme activity of cytochrome P450 aromatase of human luteinized granulosa cells in vitro, Biol. Reprod., 62, 1102, 2000.
109. Lucier, G.W., Davis, G.J., and McLachlan, J.A., Hanford Biology Symposium Monograph, Oak Ridge Technical Information Centre, 1977, 188.
110. Wardell, R.E., Seegmiller, R.E., and Bradshaw, W.S., Induction of prenatal toxicity in the rat by diethylstilbestrol, zeranol, 3,4,3',4',-tetrachlorobiphenyl, cadmium, and lead, Teratology, 26, 229, 1982.
111. Ronnback, C. and de Rooij, D.G., Effects of 3,3',4,4'-tetrachlorobiphenyl on foetal germ cells in two mouse strains after repeated treatment of the dams during and after pregnancy, Pharmacol. Toxicol., 74, 287, 1994.
112. Ishikawa, H., Tian, Y., and Yamauchi, T., Induction of micronuclei formation in preimplantation mouse embryos after maternal treatment with 2-bromopropane, Reprod. Toxicol., 15, 81, 2001.
113. Bengtsson, M. and Rydstrom, J., Regulation of carcinogen metabolism in the rat ovary by the estrous cycle and gonadotropin, Science, 219, 1437, 1983.
114. Mukhtar, H., Philpot, R.M., and Bend, J.R., The postnatal development of microsomal expoxide hydrase, cytosolic glutathione S-transferase, and mitochondrial and microsomal cytochrome P-450 in adrenals and ovaries of female rats, Drug Metab. Dispos., 6, 577, 1978.
115. Mukhtar, H., Philpot, R.M., and Bend, J.R., Epoxide-metabolizing enzyme activities and cytochrome P-450 content of rat ovaries during pregnancy, Biochem. Biophys. Res. Commun., 81, 89, 1978.
116. Bengtsson, M., Reinholt, F.P., and Rydstrom, J., Cellular localization and hormonal regulation of 7,12-dimethylbenz[a]anthracene mono-oxygenase activity in the rat ovary, Toxicology, 71, 203, 1992.
117. Heinrichs, W.L. and Juchau, M.R., Extrahepatic metabolism of drugs and other foreign compounds, SP Medical and Scientific Books, New York, 1980, 1, 319.
118. Toft, E., Becedas, L., Soderstrom, M., Lundqvist, A., and Depierre, J.W., Glutathione transferase isoenzyme patterns in the rat ovary, Chem. Biol. Interact., 108, 79, 1997.
119. Tiltman, A.J. and Haffajee, Z., Distribution of glutathione S-transferases in the human ovary: an immunohistochemical study, Gynecol. Obstet. Invest., 47, 247, 1999.
120. Meirow, D. and Nugent, D., The effects of radiotherapy and chemotherapy on female reproduction, Hum. Reprod. Update, 7, 535, 2001.
121. Anderson, D., Bishop, J.B., Garner, R.C., Ostrosky-Wegman, P., and Selby, P.B., Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks, Mutat. Res., 330, 115, 1995.
122. Sims, P., The metabolic activation of chemical carcinogens, Br. Med. Bull., 36, 11, 1980.
123. Mattison, D.R., Singh, H., Takizawa, K., and Thomford, P.J., Ovarian toxicity of benzo(a)pyrene and metabolites in mice, Reprod. Toxicol., 3, 115, 1989.
124. Bengtsson, M. and Mattison, D.R., Gonadotropin-dependent metabolism of 7,12-dimethylbenz(a)anthracene in the ovary of rhesus monkey, Biochem. Pharmacol., 38, 1869, 1989.
125. Bengtsson, M., Hamberger, L., and Rydstrom, J., Metabolism of 7,12-dimethylbenz(a)anthracene by different types of cells in the human ovary, Xenobiotica, 18, 1255, 1988.
126. Mumtaz, M.M., George, J.D., Gold, K.W., Cibulas, W., and DeRosa, C.T., ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem, Toxicol. Ind. Health, 12, 742, 1996.
127. Sims, P., Epoxides as reactive intermediates in aromatic hydrocarbon metabolism, Biochem. Soc. Trans., 3, 59, 1975.
128. Shiromizu, K. and Mattison, D.R., The effect of intraovarian injection of benzo(a)pyrene on primordial oocyte number and ovarian aryl hydrocarbon, Toxicol. Appl. Pharmacol., 76, 18, 1984.
129. Mattison, D.R. and Nightingale, M.S., Oocyte destruction by polycyclic aromatic hydrocarbons is not linked to the inducibility of ovarian aryl hydrocarbon (benzo(a)pyrene) hydroxylase activity in (DBA/2N X C57BL/6N) F1 X DBA/2N backcross mice, Pediatr. Pharmacol. (New York), 2, 11, 1982.
130. Smith, B.J., Carter, D.E., and Sipes, I.G., Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat, Toxicol. Appl. Pharmacol., 105, 364, 1990.
131. Smith, B.J., Mattison, D.R., and Sipes, I.G., Biological Reactive Intermediates IV, Plenum Press, New York, 1990, 465.
132. Keller, D.A., Carpenter, S.C., Cagen, S.Z., and Reitman, F.A., In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary, Toxicol. Appl. Pharmacol., 144, 36, 1997.
133. Fontaine, S.M., Hoyer, P.B., Halpert, J.R., and Sipes, I.G., Role of induction of specific hepatic cytochrome P450 isoforms in epoxidation of 4-vinylcyclohexene, Drug Metab. Dispos., 29, 1236, 2001.
134. Csanady, G.A., Guengerich, F.P., and Bond, J.A., Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice, Carcinogenesis, 13, 1143, 1992.
135. Watabe, T., Hiratsuka, A., Isobe, M., and Ozawa, N., Metabolism of d-limonene by hepatic microsomes to non-mutagenic epoxides toward Salmonella typhimurium, Biochem. Pharmacol., 29, 1068, 1980.
136. Giannarini, C., Citti, L., Gervasi, P.G., and Turchi, G., Effects of 4-vinylcyclohexene and its main oxirane metabolite on mouse hepatic microsomal enzymes and glutathione levels, Toxicol. Lett., 8, 115, 1981.
137. Devine, P.J., Sipes, I.G., and Hoyer, P.B., Effect of 4-vinylcyclohexene diepoxide dosing in rats on GSH levels in liver and ovaries, Toxicol. Sci., 62, 315, 2001.
138. Flaws, J.A., Salyers, K.L., Sipes, I.G., and Hoyer, P.B., Reduced ability of rat preantral ovarian follicles to metabolize 4-vinyl-1-cyclohexene diepoxide in vitro, Toxicol. Appl. Pharmacol., 126, 286, 1994.
139. Johnson, A.L., Intracellular mechanisms regulating cell survival in ovarian follicles, Anim. Reprod. Sci., 78, 185, 2003.
140. Ray, S.D., Sorge, C.L., Raucy, J.L., and Corcoran, G.B., Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminopheninduced liver injury, Toxicol. Appl. Pharmacol., 106, 346, 1990.
141. Collins, R.J., Harmon, B.V., Gobe, G.C., and Kerr, J.F., Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis, Int. J. Radiat. Biol., 61, 451, 1992.
142. Pritchard, D.J. and Butler, W.H., Apoptosis-the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity, J. Pathol., 158, 253, 1989.
143. Hirata, K., Ogata, I., Ohta, Y., and Fujiwara, K., Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats, J. Pathol., 158, 157, 1989.
144. Corcoran, G.B., Fix, L., Jones, D.P., Moslen, M.T., Nicotera, P., Oberhammer, F.A., and Buttyan, R., Apoptosis: molecular control point in toxicity, Toxicol. Appl. Pharmacol., 128, 169, 1994.
145. Springer, L.N., Flaws, J.A., Sipes, I.G., and Hoyer, P.B., Follicular mechanisms associated with 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats, Reprod. Toxicol., 10, 137, 1996.
146. Shen, W., Kamendulis, L.M., Ray, S.D., and Corcoran, G.B., Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: correlation of nuclear Ca2+ accumulation and early DNA fragmentation with cell death, Toxicol. Appl. Pharmacol., 111, 242, 1991.
147. Faa, G., Ambu, R., Congiu, T., Costa, V., Ledda-Columbano, G.M., Coni, P., Curto, M., Giacomini, L., and Columbano, A., Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver, J. Submicrosc. Cytol. Pathol., 24, 417, 1992.
148. McConkey, D.J., Hartzell, P., Nicotera, P., Wyllie, A.H., and Orrenius, S., Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress, Toxicol. Lett., 42, 123, 1988.
149. Burchiel, S.W., Davis, D.A., Ray, S.D., Archuleta, M.M., Thilsted, J.P., and Corcoran, G.B., DMBA-induced cytotoxicity in lymphoid and nonlymphoid organs of B6C3F1 mice: relation of cell death to target cell intracellular calcium and DNA damage, Toxicol. Appl. Pharmacol., 113, 126, 1992.
150. Springer, L.N., Tilly, J.L., Sipes, I.G., and Hoyer, P.B., Enhanced expression of bax in small preantral follicles during 4-vinylcyclohexene diepoxide-induced ovotoxicity in the rat, Toxicol. Appl. Pharmacol., 139, 402, 1996.
151. Hu, X., Christian, P.J., Sipes, I.G., and Hoyer, P.B., Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats, Biol. Reprod., 65, 1489, 2001.
152. Hu, X.M., Christian, P.J., Thompson, K.E., Sipes, I.G., and Hoyer, P.B., Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades, Biol. Reprod., 65, 87, 2001.
153. Takai, Y., Canning, J., Perez, G.I., Pru, J.K., Schlezinger, J.J., Sherr, D.H., Kolesnick, R.N., Yuan, J., Flavell, R.A., Korsmeyer, S.J., and Tilly, J.L., Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo, Endocrinology, 144, 69, 2003.
154. Wade, M.J., Moyer, J.W., and Hine, C.H., Mutagenic action of a series of epoxides, Mutat. Res., 66, 367, 1979.
155. Citti, L., Gervasi, P.G., Turchi, G., Bellucci, G., and Bianchini, R., The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts, Carcinogenesis, 5, 47, 1984.
156. de Raat, W.K., Induction of sister chromatid exchanges by styrene and its presumed metabolite styrene oxide in the presence of rat liver homogenate, Chem. Biol. Interact., 20, 163, 1978.
157. Albanese, R., Induction and transmission of chemically induced chromosome aberrations in female germ cells, Environ. Mol. Mutagen., 10, 231, 1987.
158. Meirow, D., Epstein, M., Lewis, H., Nugent, D., and Gosden, R.G., Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations, Hum. Reprod., 16, 632, 2001.
159. Tiveron, C., Ranaldi, R., Bassani, B., and Pacchierotti, F., Induction and transmission of chromosome aberrations in mouse oocytes after treatment with butadiene diepoxide, Environ. Mol. Mutagen., 30, 403, 1997.
160. Turchi, G., Bonatti, S., Citti, L., Gervasi, P.G., and Abbondandolo, A., Alkylating properties and genetic activity of 4-vinylcyclohexene metabolites and structurally related epoxides, Mutat. Res., 83, 419, 1981.